Insight Molecular Diagnostics (IMDX) Cash from Investing Activities (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Cash from Investing Activities of -$613000.0 for Q1 2026, up 58.55% sequentially from -$1.5 million in Q4 2025, and down 99.67% YoY from -$188.2 million in Q1 2025.
Insight Molecular Diagnostics (IMDX) Cash from Investing Activities (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics (IMDX) has 12 years of Cash from Investing Activities data on file, last reported at -$613000.0 in Q1 2026.
- Quarterly Cash from Investing Activities fell 99.67% year-over-year to -$613000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.5 million (down 339.12% YoY) and the FY2025 annual result came in at -$3.2 million, down 522.07% from the prior year.
- Cash from Investing Activities grew to -$613000.0 in Q1 2026 per IMDX's latest filing, from -$1.5 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $214000.0 in Q3 2023, with the low at -$1.6 million in Q1 2022.
- Average Cash from Investing Activities over 5 years is -$563647.1, with a median of -$349000.0 recorded in 2025.
- Year-over-year, Cash from Investing Activities surged 124.91% in 2023 and slumped 1179.17% in 2025.
- Insight Molecular Diagnostics' Cash from Investing Activities stood at -$802000.0 in 2022, then jumped by 112.84% to $103000.0 in 2023, then sank by 303.88% to -$210000.0 in 2024, then tumbled by 604.29% to -$1.5 million in 2025, then surged by 58.55% to -$613000.0 in 2026.
- Business Quant data shows IMDX's Cash from Investing Activities at -$613000.0 in Q1 2026, -$1.5 million in Q4 2025, and -$1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -32.14 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -77.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -196.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | -613,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -613,000.00 |
| Mar 31, 2026 | -613,000.00 |
| Dec 31, 2025 | -1.48 Mn |
| Dec 31, 2025 | -1.48 Mn |
| Sep 30, 2025 | -1.05 Mn |
| Sep 30, 2025 | -1.05 Mn |
| Jun 30, 2025 | -349,000.00 |
| Jun 30, 2025 | -349,000.00 |
| Mar 31, 2025 | -307,000.00 |
| Mar 31, 2025 | -307,000.00 |
| Dec 31, 2024 | -210,000.00 |
| Dec 31, 2024 | -210,000.00 |
| Sep 30, 2024 | -87,000.00 |
| Sep 30, 2024 | -87,000.00 |
| Jun 30, 2024 | -191,000.00 |
| Jun 30, 2024 | -191,000.00 |
| Mar 31, 2024 | -24,000.00 |
| Mar 31, 2024 | -24,000.00 |
| Dec 31, 2023 | 103,000.00 |
| Dec 31, 2023 | 103,000.00 |